GB1297258A - - Google Patents
Info
- Publication number
- GB1297258A GB1297258A GB1297258DA GB1297258A GB 1297258 A GB1297258 A GB 1297258A GB 1297258D A GB1297258D A GB 1297258DA GB 1297258 A GB1297258 A GB 1297258A
- Authority
- GB
- United Kingdom
- Prior art keywords
- silver
- march
- purines
- pyrimidines
- nucleoside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- NKLZSBHAQMKTDZ-UHFFFAOYSA-N pyrimidine silver Chemical class [Ag].N1=CN=CC=C1 NKLZSBHAQMKTDZ-UHFFFAOYSA-N 0.000 abstract 2
- 239000004332 silver Substances 0.000 abstract 2
- 229910052709 silver Inorganic materials 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- QCMREEOJMBTZLE-UHFFFAOYSA-N N1=CN=C2N=CNC2=C1.[Ag] Chemical compound N1=CN=C2N=CNC2=C1.[Ag] QCMREEOJMBTZLE-UHFFFAOYSA-N 0.000 abstract 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000002777 nucleoside Substances 0.000 abstract 1
- 150000003212 purines Chemical class 0.000 abstract 1
- 150000003378 silver Chemical class 0.000 abstract 1
- -1 silver nucleoside Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
- C07D473/38—Sulfur atom attached in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/005—Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80794969A | 1969-03-17 | 1969-03-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1297258A true GB1297258A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1972-11-22 |
Family
ID=25197506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1297258D Expired GB1297258A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1969-03-17 | 1970-03-17 |
Country Status (7)
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2140689A (en) * | 1983-05-30 | 1984-12-05 | Mitsui Toatsu Chemicals | Treating digestive ulcers using dna |
| US5510315A (en) * | 1991-11-08 | 1996-04-23 | Meiji Milk Products Company Limited | Freshness retentive for cut flowers |
| US7704530B2 (en) * | 2001-09-14 | 2010-04-27 | Kenji Nakamura | Antimicrobially treated material and methods of preventing coloring thereof |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61186392A (ja) * | 1985-02-12 | 1986-08-20 | エンゲルハード・コーポレーシヨン | 金化合物 |
| ES2231550T3 (es) | 2000-09-29 | 2005-05-16 | Coloplast A/S | Composiciones estabilizadas que poseen actividad antibacteriana. |
-
1970
- 1970-03-16 NL NL7003690A patent/NL7003690A/xx unknown
- 1970-03-16 CA CA077,544A patent/CA949562A/en not_active Expired
- 1970-03-16 FR FR7009283A patent/FR2034991B1/fr not_active Expired
- 1970-03-17 GB GB1297258D patent/GB1297258A/en not_active Expired
- 1970-03-17 CH CH400170A patent/CH547824A/xx not_active IP Right Cessation
- 1970-03-17 DE DE19702012717 patent/DE2012717A1/de active Pending
- 1970-03-17 BE BE747476D patent/BE747476A/xx unknown
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2140689A (en) * | 1983-05-30 | 1984-12-05 | Mitsui Toatsu Chemicals | Treating digestive ulcers using dna |
| US5510315A (en) * | 1991-11-08 | 1996-04-23 | Meiji Milk Products Company Limited | Freshness retentive for cut flowers |
| US7704530B2 (en) * | 2001-09-14 | 2010-04-27 | Kenji Nakamura | Antimicrobially treated material and methods of preventing coloring thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CH547824A (de) | 1974-04-11 |
| FR2034991A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1970-12-18 |
| DE2012717A1 (de) | 1970-10-08 |
| FR2034991B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1974-10-11 |
| BE747476A (fr) | 1970-09-17 |
| NL7003690A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1970-09-21 |
| CA949562A (en) | 1974-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT86863A (pt) | Stable gene amplification in chromosomal dna of prokaryotic microorganisms | |
| EP0846174A4 (en) | METHOD FOR STIMULATING THE PRODUCTION OF INTERFERONS IN A CELL CULTURE | |
| IT1209941B (it) | Procedimento di trattamento di cellule con proteine ossee solubili per renderle idonee a stimolare la crescita di tessuti cartilaginei ed ossei,e prodotto ottenuto | |
| DE3069426D1 (en) | Microparticles, their preparation and their biological uses, especially in the culture of diploid cells | |
| GB1286156A (en) | Sugar composition for topical application | |
| DK160429C (da) | N-heterocyclisk glycosid med antitumorvirkning, fremstilling deraf samt farmaceutisk praeparat indeholdende glycosidet | |
| GB1297258A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| ES8305198A1 (es) | Procedimiento para la obtencion de una sal comun dietetica especialmente destinada al consumo humano. | |
| GB1510847A (en) | Process for the production of saccharified starch product | |
| GB1472105A (en) | Pickling method | |
| CA946308A (en) | Antiviral complex of rna and polysaccharide | |
| GB2197651B (en) | Rna polymerase gene microorganism having said gene and the production of rna polymerase by the use of said microorganism | |
| ATE42341T1 (de) | Herstellung von uridin. | |
| Crkvenjakov et al. | The effect of 5-azacytidine on development, nucleic acid and protein metabolism in sea urchin embryos | |
| GB1331933A (en) | Antiviral ribonucleic acids | |
| Kingsbury et al. | Use of exogenous adenine to label the nucleic acids of wild-type Neisseria meningitidis | |
| Berman et al. | Orotate uptake and metabolism by human erythrocytes | |
| WO1993013204A3 (de) | Mittel zur stimulierung der teilungsaktivität tierischer zellen | |
| GB1237304A (en) | Enzyme produced by cultivating micro-organisms | |
| GB1254744A (en) | Antiviral ribonucleic acid substance | |
| Kerr et al. | The mechanism of action of interferon: a comparison of ribosomes from interferon-treated and control cells | |
| FR2070116A1 (en) | Antiviral ribonucleic acid polysaccharide - complex | |
| Kim et al. | The utilization of nucleic acid derivatives by Penicillium chrysogenum | |
| Sukhorukov | Optical properties and molecular structure of nucleic acids and their components. 1. Infrared spectra and molecular structure of cytidine and cytidylic acid in the solid phase at different pH values | |
| EP0257488A3 (en) | Novel diaminopyrimidoû4,5-d¨pyrimidine glycoside and glycotide and process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |